newsfilter
← Latest News
GlobeNewswire·

Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference

TEL AVIV, Israel, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (NASDAQ:CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with